Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: identification of a lead and initial SAR studies
- Bioorg Med Chem Lett. 2007 Jan 1;17(1):272-7. doi: 10.1016/j.bmcl.2006.09.049.
Affiliations
- 1. CNS Molecular and Cellular Biology, Centre for CNS Innovation, UCB S.A., Chemin du Foriest, B-1420 Braine L'Alleud, Belgium.
PMID: 17027269
DOI: 10.1016/j.bmcl.2006.09.049
Abstract
High-throughput screening of the UCB sample collection identified the piperidinyl-sulfonyl benzoic ester 1 as a novel agonist for CB(1) receptor with nanomolar affinity. We report here the pharmacological profile of compound 1 as well as preliminary biological activities in pain model. Diverse close analogs of 1 were purchased and the structure-affinity relationships among this novel class are discussed.
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Cannabinoid ReceptorResearch Areas: Neurological Disease